AstraZeneca I8D-MC-AZFD
Back to Drug Development Trials
![]()
Drug Development Trials
About the AstraZeneca I8D-MC-AZFD trial
Extension of Study AZES, The AMARANTH Study – A Randomized, Double-Blind, Delayed-Start Study of LY3314814 (AZD3293) in Early Alzheimer’s Disease Dementia
